PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 3 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $26,000 | -93.1% | 5,250,000 | +320.0% | 0.00% | – |
Q3 2018 | $375,000 | -25.0% | 1,250,000 | 0.0% | 0.00% | – |
Q2 2018 | $500,000 | 0.0% | 1,250,000 | 0.0% | 0.00% | – |
Q1 2018 | $500,000 | -3.1% | 1,250,000 | 0.0% | 0.00% | – |
Q4 2017 | $516,000 | -2.5% | 1,250,000 | 0.0% | 0.00% | – |
Q3 2017 | $529,000 | +53.8% | 1,250,000 | 0.0% | 0.00% | – |
Q2 2017 | $344,000 | -5.5% | 1,250,000 | 0.0% | 0.00% | – |
Q1 2017 | $364,000 | +20.9% | 1,250,000 | 0.0% | 0.00% | – |
Q4 2016 | $301,000 | -39.8% | 1,250,000 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $500,000 | +56.7% | 1,250,000 | 0.0% | 0.00% | – |
Q2 2016 | $319,000 | – | 1,250,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 2,000,000 | $36,000 | 0.00% |
Bruce & Co., Inc. | 2,000,000 | $10,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |